The price of CryoPort Inc (NASDAQ: CYRX) closed at $17.37 in the last session, up 0.64% from day before closing price of $17.26. In other words, the price has increased by $+0.11 from its previous closing price. On the day, 827893 shares were traded. CYRX stock price reached its highest trading level at $17.74 during the session, while it also had its lowest trading level at $17.15.
Ratios:
We take a closer look at CYRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.58 and its Current Ratio is at 12.23. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.76.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on August 17, 2023, initiated with a Equal-Weight rating and assigned the stock a target price of $16.
On August 10, 2023, Stephens Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $15.
UBS Downgraded its Buy to Neutral on July 18, 2023, whereas the target price for the stock was revised from $28 to $17.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 14 ’23 when Hariri Robert J sold 800 shares for $16.89 per share. The transaction valued at 13,512 led to the insider holds 12,716 shares of the business.
Hariri Robert J sold 1,000 shares of CYRX for $15,500 on Dec 11 ’23. The Director now owns 13,516 shares after completing the transaction at $15.50 per share. On Sep 06 ’23, another insider, Hariri Robert J, who serves as the Director of the company, sold 1,500 shares for $13.60 each. As a result, the insider received 20,400 and left with 14,516 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 850.50M and an Enterprise Value of 822.59M. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.60 while its Price-to-Book (P/B) ratio in mrq is 1.66. Its current Enterprise Value per Revenue stands at 3.48 whereas that against EBITDA is -70.10.
Stock Price History:
Over the past 52 weeks, CYRX has reached a high of $24.30, while it has fallen to a 52-week low of $9.00. The 50-Day Moving Average of the stock is 15.64, while the 200-Day Moving Average is calculated to be 15.12.
Shares Statistics:
According to the various share statistics, CYRX traded on average about 373.63K shares per day over the past 3-months and 349.83k shares per day over the past 10 days. A total of 48.33M shares are outstanding, with a floating share count of 47.45M. Insiders hold about 3.10% of the company’s shares, while institutions hold 104.14% stake in the company. Shares short for CYRX as of Feb 15, 2024 were 4.21M with a Short Ratio of 11.27, compared to 3.94M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.60% and a Short% of Float of 10.35%.
Earnings Estimates
The company has 10 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.29 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.38, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.11 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$0.95 and -$1.27 for the fiscal current year, implying an average EPS of -$1.16. EPS for the following year is -$0.96, with 10 analysts recommending between -$0.45 and -$1.38.
Revenue Estimates
According to 9 analysts, the current quarter’s revenue is expected to be $58.4M. It ranges from a high estimate of $61.1M to a low estimate of $57.37M. As of the current estimate, CryoPort Inc’s year-ago sales were $60.36M, an estimated decrease of -3.20% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $61.21M, a decrease of -2.60% over than the figure of -$3.20% in the same quarter last year. There is a high estimate of $65.53M for the next quarter, whereas the lowest estimate is $59.71M.
A total of 10 analysts have provided revenue estimates for CYRX’s current fiscal year. The highest revenue estimate was $237.1M, while the lowest revenue estimate was $233.37M, resulting in an average revenue estimate of $234.56M. In the same quarter a year ago, actual revenue was $237.28M, down -1.10% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $253.22M in the next fiscal year. The high estimate is $265.28M and the low estimate is $244.4M. The average revenue growth estimate for next year is up 8.00% from the average revenue estimate for this year.
